Brief: Synact Pharma Q2 Loss After Tax Rises To SEK 24.8 Mln

SynAct Pharma AB

05/08/2022 06:03

Aug 5 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SYNACT PHARMA PUBLISHES Q2 2022 INTERIM REPORT
    * Q2 OPERATING EXPENSES AMOUNTED TO SEK 26,417 (15,603)
THOUSAND
    * Q2 GROUP'S LOSS AFTER TAX AMOUNTED TO SEK 24,754 (13,137)
THOUSAND.
    * Q2 CASH FLOW FROM OPERATING ACTIVITIES AMOUNTED TO SEK
-36,922
(-16,114) THOUSAND

Source text for Eikon:  ID:nMFN3Whff3 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))